z-logo
Premium
The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre‐eclampsia
Author(s) -
Florio P.,
Reis F. M.,
Pezzani I.,
Luisi S.,
Severi F. M.,
Petraglia F.
Publication year - 2003
Publication title -
ultrasound in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.202
H-Index - 141
eISSN - 1469-0705
pISSN - 0960-7692
DOI - 10.1002/uog.29
Subject(s) - medicine , eclampsia , velocimetry , laser doppler velocimetry , uterine artery , doppler effect , pregnancy , blood flow , gestation , mechanics , physics , astronomy , genetics , biology
Objective To evaluate whether the measurement of maternal serum activin A and inhibin A adds any clinically relevant information for the prediction of pre‐eclampsia in women with altered uterine artery Doppler velocimetry at 24 weeks of gestation. Methods This was a prospective, controlled, hospital‐based study involving 58 asymptomatic pregnant women at 24 weeks' gestation in whom a diastolic notch of the uterine artery waveform was noted at routine Doppler examination. Doppler assessment of the uterine artery waveform and measurement of maternal activin A and inhibin A serum levels by specific two‐site enzyme immunoassays were performed. The cut‐off points for defining ‘high’ serum activin A and inhibin A levels for prediction of pre‐eclampsia were chosen by receiver–operating characteristics (ROC) curve analysis. The probability of developing pre‐eclampsia was calculated for several combinations of results of hormone testing. Results Activin A and inhibin A levels were higher in patients who developed pre‐eclampsia (n = 18; mean ± standarderror : 2.69 ± 0.35 ng/mL and 131.2 ± 22.7 pg/mL, respectively) than in those who did not present with pre‐eclampsia at follow‐up (n = 40; activin A: 1.79 ± 0.18 ng/mL and inhibin A: 91.9 ± 6.2 pg/mL; P < 0.05). Activin A at the cut‐off value of 1.7 multiples of the median (MoM) achieved a sensitivity of 61% and a specificity of 89%, whereas inhibin A at the cut‐off value of 1.8 MoM combined a sensitivity of 39% with a specificity of 92% for prediction of pre‐eclampsia. The probability of pre‐eclampsia was 31% in the whole study population, 86% if both activin A and inhibin A were elevated and 17% if both hormone markers were unaltered. Conclusion The measurement of serum activin A and inhibin A levels may add significant prognostic information for predicting pre‐eclampsia in pregnant women showing specific Doppler alterations in the late second trimester. Copyright © 2003 ISUOG. Published by John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom